(Bloomberg) -- Starbucks Corp. is developing in-house tools with the help of artificial intelligence that could replace some software applications it ...
Food and beverage company PepsiCo (NASDAQ:PEP) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 6.4% year on year...
Amplitude stock has had a tough 12 months with the share price down 33.7%. However, recent gains and the valuation checks suggest a picture that is cl...
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain ...
Microchip Technology (NasdaqGS:MCHP) has made its MPLAB XC Pro Compilers available free of charge. The company has also removed licensing costs for it...
Earlier this month, the Learning Resources Family of Brands expanded its back-to-school assortment at Target stores and online, adding a wide range of...
In late June 2026, Teladoc Health, Inc. was removed from multiple Russell growth and small-cap benchmarks after a period of flat sales and ongoing los...
-CNBC Interview
On July 8, 2026, Moderna, Inc. appointed veteran financial executive Michael McDonnell, former Biogen CFO, to its Board of Directors and Audit Committ...
Guggenheim analyst Vamil Divan maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $249 to $261.
Public Storage (PSA) is back in focus after the company announced that Chief Operating Officer Chris Sambar will resign at the end of July to join T-M...
Chinaâs economy has seen a growing divergence this year, with two distinct K-shaped trends moving in opposite directions.
Mettler-Toledo International stock has delivered a decline of about 13.0% over the past five years, yet the current checks suggest it is not a clear b...
Guggenheim analyst Michael Schmidt maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $205 to $235.
Competition in the multitrillion-dollar market for retirement assets is fierce among managers such as Goldman Sachs, BlackRock, Russell Investments an...
Doximity (DOCS) passes the Caviar quality screen with 177% ROIC, zero debt, and 32% EBIT growth outpacing revenue. A top-tier healthcare tech stock wi...
Cypher was founded by Kuberan Marimuthu and has received backing from Y Combinator and Coinbase Ventures.
Keybanc analyst Upal Rana maintains Broadstone Net Lease (NYSE:BNL) with a Overweight and raises the price target from $20 to $24.
https://www.bloomberg.com/news/articles/2026-07-09/meta-starts-charging-for-ai-with-muse-spark-1-1-agentic-model
Paramount's (PSKY) $110 billion acquisition of Warner Bros. Discovery (WBD) could be faced with laws
Loading...